Acquired CD20 Loss As a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma . Mediterr J Hematol Infect Dis 2026, 18 (1), e2026014. https://doi.org/10.4084/MJHID.2026.014.